2004
DOI: 10.1073/pnas.0403172101
|View full text |Cite
|
Sign up to set email alerts
|

Acute neuroprotective synergy of erythropoietin and insulin-like growth factor I

Abstract: Erythropoietin (EPO) and insulin-like growth factor I (IGF-I) are cytokines that inhibit neuronal apoptosis. However, their maximal antiapoptotic effect, even at high concentrations, is observed only when neurons are pretreated for several hours before insult. Here we show that simultaneous administration of EPO and IGF-I (EPO؉IGF-I) eliminates the preincubation period required to prevent N-methyl-D-aspartate (NMDA)-induced apoptosis in cultured rat cerebrocortical neurons. The synergistic effect of EPO؉IGF-I … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
87
1
1

Year Published

2005
2005
2014
2014

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 123 publications
(93 citation statements)
references
References 61 publications
4
87
1
1
Order By: Relevance
“…The reason was that Akt was recently reported to protect against excitotoxic neuronal death, which is believed to contribute to HIV-1-induced neuronal injury. 18,[36][37][38] Thus, we infected cerebrocortical cultures with an adenovirus encoding a dominant-interfering form of Akt or WT Akt as control. After 2 days, the cultures were exposed to HIV/gp120 SF2 in the presence or absence of MIP-1b.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…The reason was that Akt was recently reported to protect against excitotoxic neuronal death, which is believed to contribute to HIV-1-induced neuronal injury. 18,[36][37][38] Thus, we infected cerebrocortical cultures with an adenovirus encoding a dominant-interfering form of Akt or WT Akt as control. After 2 days, the cultures were exposed to HIV/gp120 SF2 in the presence or absence of MIP-1b.…”
Section: Resultsmentioning
confidence: 99%
“…To infect cerebrocortical cultures with minimal toxicity, AdVs were used at a multiplicity of infection (MOI) of 10, as described recently. 38 Neurotoxicity experiments were performed 48 h after infection with AdVs, and the presence of transduced proteins was assessed by immunofluorescence. 38 Exposure to toxins.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…For example, insulin-like growth factor I has been reported to mediate the protective effects of exercise against the progression of inherited Purkinje cell degeneration in the cerebellum (3). This growth factor helps the neural protection in culture or in vivo against proapoptotic insults (7,8). Thus insulin-like growth factor I, present in abundance in the plasma under exercised conditions, would exert a neuroprotective effect when it passes through the blood-brain barrier.…”
Section: Discussionmentioning
confidence: 99%
“…It is the discovery of EPO and its receptor in the nervous and vascular systems that has resulted in great interest and enthusiasm for the potential clinical applications of EPO, such as in Alzheimer's disease, cardiac insufficiency (Assaraf, et al, 2007, Palazzuoli, et al, 2006, and cardiac transplantation (Gleissner, et al, 2006, Mocini, et al, 2007. In the nervous system, the major sites of EPO production and secretion are in the hippocampus, internal capsule, cortex, midbrain, cerebral ECs, and astrocytes (Digicaylioglu, et al, 2004, Genc, et al, 2004. Further work has revealed several other organs as secretory tissues for EPO that include peripheral ECs (Anagnostou, et al, 1994), myoblasts (Ogilvie, et al, 2000), insulin-producing cells (Fenjves, et al, 2003), and cardiac tissue Haller, 2007, Maiese, et al, 2005c).…”
Section: Epo Expression Structure and Receptor Role In Cells And Timentioning
confidence: 99%